Home › Lung Cancer › NCT04644952
The Rise in Robotic Atypical Segmentectomies
RecruitingObservational study
The Rise in Robotic Atypical Segmentectomies: A Large Cancer Center Experience
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients who underwent a lung resection from 2004 to 2019
About the study
This study investigates the increased rate of robotic atypical segmentectomies. Segmentectomy refers to removing a section of a lobe of the lung. Reviewing patients' data retrospectively may help researchers determine whether robotic surgery has led to an increase in atypical segmentectomy.
What is being tested
- Electronic Health Record Review (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 600 · Started: Sep 15, 2020
Contact the study team
- David C. Rice · Phone: 713-563-9153
Official record on ClinicalTrials.gov — NCT04644952
Locations in the U.S.
| Texas | M D Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.